Myeloma Investment Fund®

The Myeloma Investment Fund is the first and only mission-driven venture philanthropy fund focused on accelerating a cure for multiple myeloma.

Myeloma Investment Fund Invests in Envisagenics, A.I.-Driven ...

WATERTOWN, Mass., July 11, 2024 -- Dynamic Cell Therapies (DCT) announces an investment of $1M from the Myeloma Investment Fund (MIF), ...

Myeloma Investment Fund - Case - Faculty & Research

The MIF, a venture philanthropy fund, must choose between two distinct paths. One option is a high-risk academic startup that is developing a new, early-stage ...

Multiple Myeloma Research Foundation: The MMRF

The Myeloma Investment Fund (MIF) accelerates new therapies for myeloma patients. The MIF identifies and invests in the most promising biotechnology companies ...

Myeloma Investment Fund (MIF) Partner Spotlight - YouTube

David de Graaf, Ph.D., is the Co-founder and CEO of Reverb Therapeutics. Stephanie Oestreich, Ph.D., Managing Director of the MMRF's Myeloma ...

Morse Serves as Counsel in Myeloma Investment Fund's Investment ...

The Myeloma Investment Fund is a venture philanthropy fund that invests in biotech companies developing innovative therapies and technologies to ...

Seeding the next wave of myeloma drug development - BioCentury

The Myeloma Investment Fund is putting its own spin on the venture philanthropy model — providing modest amounts of start-up capital, ...

Myeloma Investment Fund - Crunchbase Investor Profile & Investments

Myeloma Investment Fund is a new, independent, self-sustaining venture fund.

Myeloma Investment Fund invests in Nammi Therapeutics, Inc.'s ...

Jones Day advised Myeloma Investment Fund in $1 million investment in Nammi Therapeutics, Inc.'s Series B financing.

Multiple Myeloma RF - Instagram

The Myeloma Investment Fund (MIF) is the first investment fund in myeloma. Investing through this fund enables us to provide financial and strategic support.

Case Study: Myeloma Investment Fund (English version)

This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at ...

Myeloma Investment Fund - CEO and Investor Conference 2025

The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ...

MMRF invests $1M to advance DCT's new CAR T-cell therapy

The Myeloma Investment Fund is a philanthropy fund that provides financial and strategic support to advance new potential therapies for multiple ...

Myeloma Investment Fund Invests in Dynamic Cell Therapies to ...

The Myeloma Investment Fund is a venture philanthropy fund that invests in promising companies, clinical assets, and technologies in oncology.

Myeloma Investment Fund - The Case Centre

This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at ...

Myeloma Investment Fund Invests in Dynamic Cell Therapies to ...

PRNewswire/ -- Dynamic Cell Therapies (DCT) announces an investment of $1M from the Myeloma Investment Fund (MIF), the venture philanthropy ...

Multiple Myeloma Research Foundation - MMRF - Facebook

The Myeloma Investment Fund® (MIF®) is the first investment fund in myeloma. Investing through this fund enables us to provide financial and ...

Multiple Myeloma RF on X: "We are proud to share an article by ...

We are proud to share an article by MMRF President & CEO, Michael Andreini, & Managing Director of our #Myeloma Investment Fund, ...

Myeloma Investment Fund - BIO International Convention 2024

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity. Loading.

Myeloma Investment Fund - BioCentury Company Profiles - BCIQ

Myeloma Investment Fund ... How the Myeloma Investment Fund approaches venture philanthropy and views the future of the myeloma treatment landscape.